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Glomerular filtration rate is superior to serum
creatinine for prediction of mortality after
thoracoabdominal aortic surgery
Tam T. T. Huynh, MD, Randolph G. Statius van Eps, MD, Charles C. Miller III, PhD,
Martin A. Villa, MD, Anthony L. Estrera, MD, Ali Azizzadeh, MD, Eyal E. Porat, MD,
Jennifer S. Goodrick, MS, RN, and Hazim J. Safi, MD, Houston, Tex
Background: Clinically evident renal disease (dialysis, history of renal insufficiency, or serum creatinine >2.0 mg/dL) is
a known risk factor for mortality after thoracoabdominal aortic aneurysm repair. We extended this concept to the
questions of whether subclinical renal disease is also a risk factor and how best to identify subclinical disease. We
hypothesized that the glomerular filtration rate (GFR) would be a more sensitive determinant of renal function than
serum creatinine alone.
Methods: Between 1991 and 2004, we repaired 1106 thoracoabdominal aortic aneurysms and descending thoracic aortic
aneurysms. The median age was 67 years. There were 400 (36%) women and 706 (64%) men. We estimated GFR by using
the Cockcroft-Gault equation. We divided baseline serum creatinine and baseline GFR into quartiles and estimated the
association of the quartiles with 30-day postoperative mortality by 2 testing. We further subdivided the population into
patients with and without clinically evident renal disease and repeated the analysis in the patients without clinically
apparent disease (n  869).
Results: Clinically apparent renal disease was highly associated with 30-day mortality (odds ratio, 3.2; P < .0001). In all
patients, serum creatinine quartile and GFR quartile were also both highly significantly associated with 30-day mortality
(P < .0001). In patients without clinically apparent renal disease, both creatinine and GFR predicted additional
mortality, but GFR was a much stronger predictor (P < .02 for creatinine vs <.0001 for GFR). In these patients,
mortality ranged from 5% in the best GFR quartile to 27% in the worst. Taken as continuous variables in logistic
regression equations, serum creatinine had no discrimination in patients without clinical disease (P .73), whereas GFR
remained strong (P <.0001).
Conclusions: Preoperative renal function is an important determinant of early mortality even in patients without clinically
evident disease. Estimated GFR is a much more powerful determinant of mortality risk than serum creatinine alone.
(J Vasc Surg 2005;42:206-12.)Surgical repair remains the gold standard treatment for
thoracoabdominal aortic aneurysms (TAAA; Fig 1).
Chronic renal disease is a known risk factor for increased
mortality and morbidity after this type of surgery.1,2 Renal
failure requiring dialysis is the most visible outcome of
chronic renal disease. In the United States, more than
320,000 patients have end-stage renal disease treated by
dialysis every year.3 The prevalence of earlier stages of
chronic renal disease is even higher.4 Despite advances in
surgical techniques and organ protection, renal failure re-
mains a vexing problem in the surgical treatment of
TAAAs.1,2,5,6 Published reports on thoracoabdominal aor-
tic surgery have had varying definitions of renal disease.5,7-9
Most authors have used serum creatinine as a crude index of
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206renal function.1,5,8,10 We have previously defined preoper-
ative chronic renal disease as a requirement for dialysis,
serum creatinine greater than 2.0 mg/dL, or a history of
renal insufficiency.1,2,5,6
According to the recent guidelines of the National
Kidney Foundation for assessing kidney disease, estimates
of glomerular filtration rate (GFR) are the best overall
indices of the level of renal function.4 Serum creatinine
alone is not an accurate index of GFR. The level of GFR
should be estimated from prediction equations that, in
addition to the serum creatinine concentration, take into
account some or all of the following variables: age, sex,
race, and body size.4 The Cockroft-Gault equation is the
most commonly used equation to estimate GFR.4,11 We
hypothesized that estimated GFR would be a more sensi-
tive determinant of renal function than serum creatinine
alone in predicting patient outcome after TAAA surgery. In
this study, we evaluated how best to identify subclinical
renal disease and whether subclinical renal disease is also a
risk factor for 30-day mortality in patients undergoing
TAAA surgery.
MATERIALS AND METHODS
Between 1991 and 2004, we repaired 1106 TAAAs and
descending thoracic aortic aneurysms. Seven hundred six
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age was 67 years (range, 8-90 years). We estimated GFR by
using the Cockcroft-Gault equation4,11:
(140 age) weight ⁄ 72 serum creatinine
where age is in years, actual body weight is in kilograms,
and serum creatinine is in milligrams per deciliter. For
women, the equation is multiplied by 0.85.4,11 We divided
the baseline preoperative serum creatinine level and esti-
mated GFR into quartiles, and then we evaluated the
association of the quartiles with 30-day mortality by 2 in
all patients. Clinically evident renal disease is now defined as
a serum creatinine level greater than 1.5 mg/dL on admis-
sion, a history of renal insufficiency, or a requirement for
dialysis. A history of renal insufficiency refers to a medical
record documentation, the patient’s giving a history of
renal insufficiency, or a previous requirement for dialysis.
Patients are deemed without clinically evident renal disease
if they do not have any of these characteristics. We then
repeated the analysis in patients without clinically evident
renal disease.
Our operative technique for repairing TAAAs and de-
scending thoracic aortic aneurysms has been described
previously.1,5,6,12 In brief, since 1992 we have used adjunct
distal aortic perfusion, cerebrospinal fluid drainage, and
moderate hypothermia (33°C-34°C) in all patients except
those with complications. These include hemodynamic in-
stability due to rupture of the aneurysm, active infection,
and severe coagulopathy. Cerebrospinal fluid pressure is
maintained at less than 10 mm Hg throughout the opera-
tion and for 3 days after surgery by using a lumbar drain
placed percutaneously in the third or fourth lumbar space
Fig 1. Classification of thoracoabdominal aortic aneury
renal arteries. Extent II, distal to the left subclavian ar
intercostal space to below the renal arteries. Extent IV,
abdominal aortic aneurysm). Extent V, below the sixt
Descending thoracic aortic aneurysm.immediately before surgery. To achieve distal aortic perfu-sion, we cannulate the left atrium through the left inferior
pulmonary vein or atrial appendage. We attach a BioMedi-
cus pump (Minneapolis, Minn) with an in-line heat ex-
changer to this cannula. We then establish arterial inflow by
cannulating the left common femoral artery or, if the
femoral artery is not accessible, the distal aorta. To mini-
mize the ischemic time to the spinal cord, viscera, and
kidneys, we use a sequential cross-clamping technique.
Other adjunctive measures include the use of visceral and
renal perfusion with cold blood or a crystalloid solution to
decrease the renal temperature to less than 15°C (Fig 2).
Data collection for this study was approved by the
Committee for the Protection of Human Subjects (Institu-
tional Review Board) of the University of Texas Health
Sciences Center at Houston. Data were collected prospec-
tively by a trained master’s level research nurse and entered
into our specially designed Microsoft Access database (Mi-
crosoft Corp, Redmond, Wash). On occasion, missing data
were abstracted retrospectively by reviewing patients’ med-
ical records. Data were entered into the database and stored
on a secure server. Analyses were conducted by using SAS
software version 8.2 (SAS Institute, Cary, NC) running
under Windows XP Professional (Microsoft). Univariate
statistics were computed by using contingency table meth-
ods (Tables I and II). Multivariate analysis was performed
by using multiple logistic regression (Table III). Continu-
ous data were divided into quartiles for contingency table
analysis and were also evaluated in their continuous form by
univariate logistic regression. The preoperative serum cre-
atinine level was the level obtained on the day of admission.
Preoperative GFR was calculated according to the Cock-
roft-Gault equation, by using the serum creatinine and
Extent I, distal to the left subclavian artery to above the
to below the renal arteries. Extent III, from the sixth
12th intercostal space to below the renal arteries (total
rcostal space to just above the renal arteries. DTAA,sms.
tery
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h inteweight on admission. Baseline serum creatinine and GFR
to 3
JOURNAL OF VASCULAR SURGERY
August 2005208 Huynh et alwere compared across aneurysm extents by using one-way
analysis of variance (Tables IV and V). Changes from
preoperative to postoperative serum creatinine and GFR
were also evaluated by analysis of variance (Tables VI and
VII). The highest postoperative creatinine level was used in
this subgroup analysis. The null hypothesis for statistical
tests was rejected at P  .05.
RESULTS
Our 30-day mortality was 14.6% (162/1106). Aneu-
rysm rupture and pre-existing renal disease were strong
predictors for mortality (Table I). There was no difference
Fig 2. Visceral and renal perfusion. The BioMedicus
mesenteric artery, and renal artery with cold blood (or c
lower extremities to maintain body temperature at 33°Cin mortality between women and men. Acute dissection,redo surgery, and aneurysm extent were not significant risk
factors for death. In all patients, baseline serum creatinine
quartile and GFR quartile were both highly significantly
associated with 30-day mortality (P .0001). In patients
without clinically apparent renal disease, both serum creat-
inine andGFR predicted additional mortality, but GFRwas
amuch stronger predictor (P.02 for creatinine vs.0001
for GFR). In these patients, mortality ranged from 5% in
the best GFR quartile to 27% in the worst. Mortality also
correlated strongly with worsening renal disease, in relation
to the severity stages defined by the National Kidney Foun-
dation (Table II). Taken as continuous variables in logistic
p circuit is set up to perfuse the celiac axis, superior
loid solution) and, at the same time, warm blood to the
5°C.pum
rystalregression equations, serum creatinine had no discrimina-
be co
earso
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GFR remained a strong predictor (P .0001). In multiple
logistic regression analysis, only rupture and GFR were
significant predictors of early mortality (Table III). Creat-
inine was not significant in this model. Plotting preopera-
tive serum creatinine vs GFR (Fig 3) showed that GFR
Table I. Univariate analysis of risk factors for 30-day mor
Variable No. patients (%) No. De
Overall 1106 (100.0) 162
Female 400 (36.2) 65
Male 706 (63.8) 97
COPD 363 (32.8) 59
No COPD 743 (67.2) 103
Acute
Dissection 45 (4.1) 7
Otherwise 1061 (95.9) 155
Extent II 215 (19.5) 38
Other extents 891 (80.5) 124
Rupture 73 (6.6) 24
Intact 1033 (93.4) 138
Redo 72 (6.5) 14
Primary 1034 (93.5) 148
Adjunct§ 823 (74.4) 115
No adjunct 283 (25.6) 47
Renal disease 237 (21.4) 67
No renal disease 869 (78.6) 95
GFR (mL/min)

49 223 (24.3) 62
49-64 228 (24.9) 40
65-90 232 (25.3) 23
90 234 (25.5) 13
Creatinine (mg/dL)
¶
0.9 361 (35.6) 36
0.9-1.1 242 (23.8) 33
1.2-1.4 201 (19.9) 25
1.5 210 (20.7) 59
CI, confidence interval; COPD, chronic obstructive pulmonary disease; GF
*For dichotomous variables, the odds ratio represents a test against a referenc
to the increase in odds associated with a one-unit increase in the variable valu
the continuous variable.
†This reflects the units against which its companion odds ratio is computed
‡P indicates the probability of type I statistical error (common P value). Valu
parentheses are univariate logistic regression likelihood ratio p values.
§Adjunct includes combined distal aortic perfusion, cerebrospinal fluid drai
GFR was estimated by using the Cockroft-Gault equation; GFR could not
¶Creatinine data were not available for 92 cases.
Table II. Thirty-day mortality according to stages of kidn
Stage*
GFR
(mL/min per 1.73 m2)† N
1 90
2 60-89
3 30-59
4 15-29
5 15 or dialysis
GFR, Glomerular filtration rate.
*Stages are defined according to the National Kidney Foundation.
†GFR could not be computed for 189 cases.
‡P indicates the probability of type I statistical error (common P value) by Pmisses an abnormal creatinine in only 2 occurrences (twoboxes), but creatinine misses an abnormal GFR 572 (71%)
of 804 times. That is, when creatinine is normal, GFR is
abnormal 71% of the time in this population.
When mortality was evaluated according to these
thresholds, it was 94 (11.7%) of 804 among patients with
normal creatinine, compared with 13 (5.6%) of 234 among
%) Odds ratio* 95% CI† P value‡
)
) 1.21 0.87-1.71 .26
) 1
) 1.21 0.85-1.71 .29
) 1
) 1.08 0.47-2.46 .86
) 1
) 1.33 0.89-1.98 .17
) 1
) 3.18 1.89-5.34 .0001
) 1
) 1.45 0.79-2.66 .24
) 1
) 0.82 0.56-1.18 .28
) 1
) 3.21 2.25-4.57 .0001
)
) .98 .97-.99 .0001
) (.0001)
1.02 .99-1.04 .0001
) (.30)
)
)
merular filtration rate.
ory whose referent odds ratio is 1. For continuous data, the odds ratio refers
hough continuous data are presented in quartiles, the odds ratios are against
fidence intervals are test based.
hout parentheses are Pearson Chi-square probabilities. Probability values in
and moderate hypothermia.
mputed for 189 cases.
sease
tients (%) No. Deaths (%) P value‡
(25.8) 13 (5.4) .0001
(31.3) 37 (12.8)
(35.0) 70 (21.6)
(4.4) 12 (29.3)
(3.5) 12 (37.5)
n 2.tality
aths (
(14.6
(16.3
(13.7
(16.3
(13.9
(15.6
(14.6
(17.7
(13.9
(32.8
(13.4
(19.4
(14.3
(13.9
(16.6
(28.3
(10.9
(27.8
(17.5
(9.9)
(5.6)
(9.9)
(13.6
(12.4
(28.1
R, glo
e categ
e. Alt
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es wit
nage,ey di
o. Pa
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32those with normal GFR. Further analysis of renal function
with
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patients with descending thoracic aortic aneurysms had the
highest preoperative GFR compared with all other TAAA
Table III. Multiple logistic regression model effect of var
Variable Parameter estimate
Intercept 0.2717
GFR 0.0233
Creatinine* 0.0326
Rupture 0.9665
CI, Confidence interval; GFR, glomerular filtration rate.
*The term for creatinine would ordinarily be positive (increasing mortality
overlaps the null value of 1.0.
Table IV. Glomerular filtration rate by aneurysm extent
Extent
Mean GFR
(mL/min per
1.73 m2) Lower CI Upper CI
I 67.6 62.7 72.5
II 71.6 66.5 76.6
III 68.2 60.4 76.0
IV 66.0 60.0 72.0
V 65.0 55.4 74.6
Descending* 80.5 76.3 84.7
GFR, Glomerular filtration rate; CI, confidence interval.
*Significantly greater GFR (P .008) than all other extents.
Table V. Serum creatinine by aneurysm extent
Extent
Mean creatinine
(mg/dL) Lower CI Upper CI
I 1.24 0.64 1.84
II 1.39 0.78 2.00
III 1.38 0.42 2.33
IV* 2.24 1.51 2.96
V 1.18 0.04 2.40
Descending 1.57 1.06 2.08
CI, Confidence interval.
*Significantly (P .04) greater than extent I.
Table VI. Change in preoperative to postoperative GFR
by aneurysm extent
Extent
GFR change from
before surgery
(mL/min per 1.73 m2) Lower CI Upper CI
I 8.8 14.2 3.4
II*† 20.1 25.9 14.3
III*† 24.1 33.1 15.2
IV*† 21.3 28.0 14.6
V 11.0 21.6 0.5
Descending 5.5 10.2 0.8
GFR, Glomerular filtration rate; CI, confidence interval.
*Significantly (P .006) worse than extent I.
†Significantly (P .0004) worse than descending.extents (Table IV). After surgery, these patients also hadthe best preserved GFR, as compared with significant de-
creases in GFR for TAAA extents II, III, and IV (Table VI).
Conversely, the highest preoperative serum creatinine level
was found in patients with extent IV (Table V), and the
postoperative changes in serum creatinine did not correlate
with the TAAA extent (Table VII).
DISCUSSION
Major advances have been made in the surgical treat-
ment of TAAAs. The high incidence of paraplegia and
paraparesis after TAAA surgery during the cross-clamp-
and-sew era has been markedly reduced by using adjunct
cerebrospinal fluid drainage, distal aortic perfusion, and
passive moderate hypothermia, particularly in patients with
extent II.1 Chronic renal disease remains an important risk
factor for mortality and morbidity.1,2,8 We have identified
that patients with known pre-existing renal disease are at
higher risk for 30-day and late mortality and also have an
increased incidence of immediate and delayed neurologic
deficits.1,2,5,13-15 Accordingly, we have shifted our atten-
tion to the evaluation of preoperative renal disease and its
effect on patient outcome.
In this study, we confirmed that preoperative renal
disease is an important predictor of 30-day mortality for
TAAA surgery. In addition, we uncovered that subclinical
renal disease is prevalent in our patient population, with
mean GFR ranging from 65 to 80 mL/min per 1.73 m2
(stage 2: mild to moderate renal disease) across all TAAA
extents and descending thoracic aortic aneurysms.4 Using
serum creatinine levels of greater than 1.5 mg/dL as a
marker for renal disease would fail to detect almost three
s on mortality
ds ratio 95% CI P value
0.98 0.97-0.99 .0001
0.97 0.89-1.05 .4255
2.63 1.42-4.86 .003
increasing creatinine), but it is not significant, and the confidence interval
Table VII. Change in preoperative to postoperative
serum creatinine by aneurysm extent
Extent
Creatinine change
from before surgery Lower CI Upper CI
I 0.45 0.23 1.12
II* 0.97 0.26 1.69
III 1.08 0.04 2.20
IV 0.02 0.86 0.81
V 0.73 0.63 2.08
Descending 0.02 0.61 0.56
CI, Confidence interval.
*Significantly (P .05) worse than descending.iable
Odquarters of patients with decreased GFR (90 mL/min).
al G
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operative renal disease was associated with increased 30-day
mortality. For TAAA patients with subclinical renal disease,
the estimatedGFR is a muchmore powerful determinant of
mortality than the serum creatinine level alone. Serum
creatinine is influenced by muscle mass and hydration, and
its level alone may fail to detect mild to moderate stages of
kidney disease.4 Presumably, this is the reason for the
mortality rates of 9% to 13% in patients who have a normal
preoperative serum creatinine level (less than 1.5 mg/dL)
but who may have subclinical renal disease. Using GFR as a
measure of renal function, the 30-daymortality was only 5%
for patients with a normal GFR (90 mL/min per 1.73
m2); it was doubled for patients with mild renal disease
(stage 2; GFR of 60-89 mL/min per 1.73 m2), and it
approached 22% in patients with moderate renal disease
(stage 3; GFR of 30-59 mL/min per 1.73 m2).
The other important finding in our studywas the reduced
preoperative renal function in all patients with TAAA com-
pared with those with descending thoracic aortic aneurysms,
according to their estimated GFR. This difference would not
have been detected if preoperative renal function were based
on the serum creatinine level alone. We postulate that there is
an increased incidence of antecedent renal disease when the
aneurysmal process involves the abdominal aorta related to
atherosclerosis of the renal arteries, dissection, or atheroem-
Fig 3. Glomerular filtration rate (GFR) vs serum crea
mg/dL andGFR 90mL/min. *Correctly classified by bo
GFR and abnormal creatinine. Creatinine misses abnormboli. In addition, although we did not focus on postoperativerenal function in this study, GFRwas amore sensitive index of
changes in renal function than serum creatinine alone. How-
ever, future studies are required to further delineate the differ-
ential renal function with regard to preoperative aneurysm
extent and surgical repair.
The Cockroft-Gault equation is a simple method for
estimating the GFR.11 Although the equation was origi-
nally designed to calculate creatinine clearance, it has been
validated as a good estimate of GFR and is commonly used
in clinical practice to evaluate renal function.4,16-18 A
newer, more complex equation, known as modification of
diet in renal disease, produces a direct normalized index of
GFR.4 The modification of diet in renal disease equation is
available on the Internet (http://www.kidney.org/
professionals/kdoqi/gfr_calculator.cfm) and is increas-
ingly being used by clinicians and researchers.16,19 The
serum creatinine level alone is a crude index of renal func-
tion and has no discrimination in patients with subclinical
disease. Because evidence supporting the importance of
chronic renal disease in cardiovascular diseases is emerging,
we propose that estimates of GFR should be used to
evaluate renal function, particularly for population such as
ours with a high prevalence of subclinical renal disease.16-20
In summary, preoperative renal function is an impor-
tant determinant of early mortality, even in patients with-
out clinically evident disease. Elective TAAA surgery
e. Reference lines are at normal values: creatinine 1.5
ts;normal creatinine and abnormal GFR;□ normal
FR in 71% of cases. Pre-op, Preoperative.tinin
th tesshould be considered with great caution for patients who
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experience, estimated GFR is a much more powerful pre-
dictor of mortality risk than serum creatinine alone. Future
studies are required to further elucidate the relationship
between pre-existing renal disease and postoperative mor-
tality after TAAA surgery.
ACKNOWLEDGMENT
We gratefully acknowledge Kirk Soodhalter for his
editorial assistance.
REFERENCES
1. Safi HJ, Miller CC III, Huynh TT, Estrera AL, Porat EE, Winnerkvist
AN, et al. Distal aortic perfusion and cerebrospinal fluid drainage for
thoracoabdominal and descending thoracic aortic repair: ten years of
organ protection. Ann Surg 2003;238:372-80; discussion 380-1.
2. SafiHJ, Huynh TTT,HassounHT,Miller CC III, Estrera AL. Prevent-
ing renal failure in thoracoabdominal aortic aneurysm repair. Perspect
Vasc Surg Endovasc Ther 2004;16:3-11.
3. National Institutes of Health, Diabetes and Digestive and Kidney
Diseases. US renal data system, USRDS 2000 annual data report.
Available at: URL: http://www.usrds.org/atlas_2000.htm. Accessed
January 2005.
4. K/DOQI clinical practice guidelines for chronic kidney disease: evalu-
ation, classification, and stratification. Am J Kidney Dis 2002;39(2
Suppl 1):S1-266
5. Safi HJ, Harlin SA, Miller CC, Iliopoulos DC, Joshi A, Mohasci TG, et
al. Predictive factors for acute renal failure in thoracic and thoracoab-
dominal aortic aneurysm surgery [published erratum appears in J Vasc
Surg 1997;25:93]. J Vasc Surg 1996;24:338-44; discussion 344-5.
6. Hassoun HT, Miller CC III, Huynh TT, Estrera AL, Smith JJ, Safi HJ.
Cold visceral perfusion improves early survival in patients with acute
renal failure after thoracoabdominal aortic aneurysm repair. J Vasc Surg
2004;39:506-12.
7. Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ. Experience
with 1509 patients undergoing thoracoabdominal aortic operations. J
Vasc Surg 1993;17:357-68; discussion 368-70.
8. Kashyap VS, Cambria RP, Davison JK, L’Italien GJ. Renal failure after
thoracoabdominal aortic surgery. J Vasc Surg 1997;26:949-55; discus-9. Jacobs MJ, van Eps RG, de Jong DS, Schurink GW, Mochtar B.
Prevention of renal failure in patients undergoing thoracoabdominal
aortic aneurysm repair. J Vasc Surg 2004;40:1067-73; discussion 1073.
10. Hansen KJ, Cherr GS, Dean RH. Dialysis-free survival after surgical
repair of ischemic nephropathy. Cardiovasc Surg 2002;10:400-4.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from
serum creatinine. Nephron 1976;16:31-41.
12. Galla JD, Ergin MA, Sadeghi AM, Lansman SL, Danto J, Griepp RB. A
new technique using somatosensory evoked potential guidance during
descending and thoracoabdominal aortic repairs. J Card Surg 1994;9:
662-72.
13. Estrera AL, Miller CC III, Huynh TT, Porat E, Safi HJ. Neurologic
outcome after thoracic and thoracoabdominal aortic aneurysm repair.
Ann Thorac Surg 2001;72:1225-30; discussion 1230-1.
14. Estrera AL, Miller CC III, Huynh TT, Azizzadeh A, Porat EE, Vin-
nerkvist A, et al. Preoperative and operative predictors of delayed
neurologic deficit following repair of thoracoabdominal aortic aneu-
rysm. J Thorac Cardiovasc Surg 2003;126:1288-94.
15. Azizzadeh A, Huynh TT, Miller CC III, Estrera AL, Porat EE, Shein-
baum R, et al. Postoperative risk factors for delayed neurologic deficit
after thoracic and thoracoabdominal aortic aneurysm repair: a case-
control study. J Vasc Surg 2003;37:750-4.
16. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm
LL, et al. Kidney disease as a risk factor for development of cardiovas-
cular disease: a statement from the American Heart Association Coun-
cils on Kidney in Cardiovascular Disease, High Blood Pressure Re-
search, Clinical Cardiology, and Epidemiology and Prevention.
Hypertension 2003;42:1050-65.
17. Knobler H, Zornitzki T, Vered S, Oettinger M, Levy R, Caspi A, et al.
Reduced glomerular filtration rate in asymptomatic diabetic patients:
predictor of increased risk for cardiac events independent of albumin-
uria. J Am Coll Cardiol 2004;44:2142-8.
18. Dumaine R, Collet JP, Tanguy ML, Mansencal N, Dubois-Rande JL,
Henry P, et al. Prognostic significance of renal insufficiency in patients
presenting with acute coronary syndrome (the prospective multicenter
SYCOMORE study). Am J Cardiol 2004;94:1543-7.
19. TonelliM, Isles C, CurhanGC, Tonkin A, PfefferMA, Shepherd J, et al.
Effect of pravastatin on cardiovascular events in people with chronic
kidney disease. Circulation 2004;110:1557-63.
20. Saw J, Gurm HS, Fathi RB, Bhatt DL, Abou-Chebl A, Bajzer C, et al.
Effect of chronic kidney disease on outcomes after carotid artery stent-
ing. Am J Cardiol 2004;94:1093-6. Submitted Jan 20, 2005; acceptedsion 955-7. Mar 30, 2005.
COLLECTIONS OF PAPERS
On the Web version of the Journal, selected articles have been grouped together for the convenience of the
readers. The current collections include the following:
American Board of Vascular Surgery
Editorial Comments
History
Reporting Standards
Technical Notes
Basic Science Reviews
Guidelines
Lifeline Research Meeting Abstracts
Reviews
